SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0000921895-20-003037
Filing Date
2020-11-18
Accepted
2020-11-18 17:16:44
Documents
5
Effectiveness Date
2020-11-18

Document Format Files

Seq Description Document Type Size
1 dfan14a12766002_11182020.htm DFAN14A 19573
2 EXHIBIT 99.1 - INVESTOR PRESENTATION ex991dfan14a12766002_111820.pdf DFAN14A 1855236
3 GRAPHIC image_001.jpg GRAPHIC 22370
4 GRAPHIC image_002.jpg GRAPHIC 20669
5 GRAPHIC image_003.jpg GRAPHIC 17680
  Complete submission text file 0000921895-20-003037.txt   2655588
Mailing Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129
Business Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129 617-259-1970
ZIOPHARM ONCOLOGY INC (Subject) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A | Act: 34 | File No.: 001-33038 | Film No.: 201325991
SIC: 2834 Pharmaceutical Preparations

Mailing Address 141 MECOX ROAD WATER MILL NY 11976
Business Address
Postma Robert W (Filed by) CIK: 0001827847 (see all company filings)

Type: DFAN14A